Ambit Biosciences' Grant

Ambit Biosciences raised a round of funding on December 21, 2009. Investors include Qualifying Therapeutic Discovery Project.

Ambit Biosciences is a biopharmaceutical company engaged in the development of a robust pipeline of small molecule kinase inhibitors for the treatment of cancer, inflammatory disease and other indicat…

Articles about Ambit Biosciences' Grant: